LungÕ 2026 – Virtual Global Congress on Lung Oncology
ASTRIDE Bridges the Gap: Serplulimab Matches 32% Two-Year Survival in U.S. Patients with Small Cell Lung Cancer
Daniel Malarek and a Wish for Oncology: A Future Where Breakthroughs Reach Every Patient
Perioperative Ivonescimab Shows Promising Pathological Responses in Resectable NSCLC: Phase II Trial Reports 70.1% MPR and 50.7% pCR
From TAILORx to OPTIMA: Genomic Testing Expands Chemotherapy De-escalation in Higher-Risk HR-Positive Breast Cancer
London Global Cancer Week 2026: Highlights From November 2–4
Expert Discussion at COGC 2026: The Right First Investments in Precision Oncology
BeOne Medicines’ Zanubrutinib Combination Gains FDA Priority Review for First-Line Mantle Cell Lymphoma
OncoDaily RT is the dedicated radiation oncology platform of OncoDaily, focused on the rapidly evolving field of radiotherapy and cancer treatment. It covers clinical research, treatment advances, technology, education, and global collaboration, including precision radiotherapy, stereotactic radiotherapy, brachytherapy, adaptive radiotherapy, proton therapy, artificial intelligence, treatment toxicity, survivorship, patient-centered care, and integration with systemic treatments. Through OncoDaily RT, radiation oncologists, medical physicists, researchers, trainees, industry partners, and multidisciplinary cancer care professionals can follow the latest research, emerging technologies, treatment innovations, congress updates, expert perspectives, interviews, articles, social media coverage, and expert-led discussions, while sharing knowledge and advancing radiation oncology worldwide.
